Research & Development

欧美视频欧美成人ST康美:终止实施限制性股票激励计划

發布時間︰

欧美视频 九六欧美成 就憑那精窄的兩道,算是軌, 蕪湖施長春,曼郎少年,有衛叔寶之稱。余宰江寧時,秦澗泉屢為致意,雲“將渡江求見”。已而病亡。有《上冢歌》雲︰“白楊樹,城東路,野草萋萋葬人處。挈植提壺出郭行,可憐今日又清明。富家冢高高傍嶺,貧家冢低低亞畛;冢中貧富人不同,一樣酒澆不能飲。暝煙慘淡日西斜,挈植提壺還返家。一線陰風旋不定,紙錢飛上棠梨花。”人

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.


Connect? Registries


The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo